Biocon Biologics Email Format
Biotechnology ResearchKarnataka, India5001-10000 Employees
Biocon Biologics, a subsidiary of Biocon Limited, operates as a fully integrated biosimilars company based in Electronics City, Karnataka, India. Its research portfolio covers biosimilars for diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from its portfolio have advanced from laboratory development to commercialization in developed markets, including the United States, the European Union, Australia, Canada, and Japan. The organization employs a sizable workforce and maintains a global footprint focused on expanding access to biologic therapies. As a player in biotechnology research, Biocon Biologics targets healthcare providers, patients, and payers seeking affordable biosimilars in major markets, addressing cost and access challenges. A notable recent development is the launch of Denosumab biosimilars Bosaya and Aukelso in the United States.